Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial

作者：Zan Hou, Baiqiang Dong, Qiwei Yao, Hualin Chen, Q. Shao, Min-Ying Li, Jianyang Wang, Keying Chen, Zhengfei Zhu, Fang Peng, Shihong Wei, Xiao Hu, Jiancheng Li, Meilian Liu, Bingang Xu, Siming Zheng, Nan Bi, Shuohan Zheng, Qingqing Xu, Biqi Chen, Chenfei Wu, Rui Li, Wei Chen, Xin Liu, Yuchen Tian, Xuan Li, Suying Guo, Lei Zhao, Yujia Zhu, Ling Cai, Qiaoqiao Li, Li Li, Huilan Zhang, Chen Hu, Lühua Wang, Qiwen Li, Baoqing Chen, Ming Chen · 发表于：The Lancet Oncology · 年份：2025 · DOI：10.1016/s1470-2045(25)00515-7 · 被引用次数：10 · 研究领域：Effects of Radiation Exposure、Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis、Lung Cancer Treatments and Mutations